Understand injectable treatment options
Vivitrol and relapse prevention services play a critical role in a comprehensive [long acting injectable opioid dependency treatment] approach. At Carolina Energetics, you can access medically supervised monthly injections designed to support your recovery journey. These include Vivitrol, an extended-release naltrexone injection for alcohol use disorder and opioid relapse prevention, and Sublocade, a monthly buprenorphine injection for opioid use disorder. By choosing injectable medication-assisted therapy (MAT), you receive consistent dosing, reduce daily medication decisions, and benefit from integrated support services.
Vivitrol for relapse prevention
Vivitrol is an extended-release formulation of naltrexone approved by the FDA to prevent relapse in both alcohol use disorder and opioid use disorder. Once administered intramuscularly at 380 mg every four weeks, Vivitrol binds to mu opioid receptors in your brain, blocking the euphoric and sedative effects of opioids and reducing cravings for alcohol [1]. To ensure safety and effectiveness:
- You must complete detoxification and be opioid-free for at least 7–10 days (14 days for methadone users) before your first injection to avoid precipitated withdrawal [2].
- Vivitrol works best when combined with counseling or behavioral therapies as part of a structured outpatient plan such as our [vivitrol program outpatient clinic].
- You and your care team will monitor any side effects and adjust your plan to maintain your progress.
Sublocade for opioid use disorder
Sublocade delivers buprenorphine, a partial opioid agonist, through a monthly subcutaneous injection. This steady-release formulation helps you stabilize withdrawal symptoms and curb cravings without daily dosing. Sublocade has been shown to improve retention in treatment and reduce illicit opioid use when compared to sublingual buprenorphine formulations. Key points include:
- Monthly dosing of 100 mg or 300 mg under medical supervision.
- Integration with behavioral therapies to address underlying triggers.
- Support from our [sublocade medication management support] team for injection scheduling and follow-up.
| Feature | Vivitrol | Sublocade |
|---|---|---|
| Medication class | Naltrexone (opioid antagonist) | Buprenorphine (partial agonist) |
| FDA approved use | Alcohol use disorder and opioid relapse prevention | Opioid use disorder |
| Dosing | 380 mg IM every 4 weeks | 100–300 mg SC monthly |
| Mechanism | Blocks opioid receptors to reduce cravings | Provides steady buprenorphine levels |
| Counseling requirement | Yes | Yes |
| Typical insurance options | Co-pay savings, Medicaid, commercial coverage | Medicaid, commercial insurance |
Maintain consistent medication levels
Injectable MAT options remove the peaks and troughs associated with daily dosing. By receiving a single injection each month, you maintain stable medication levels that support cognitive clarity and emotional balance.
How monthly injections work
When you receive Vivitrol or Sublocade, the formulation releases medication gradually into your bloodstream. This steady delivery:
- Delivers therapeutic doses without the need for daily pills.
- Reduces risk of missed doses and the associated return of cravings.
- Simplifies your treatment routine, so you can focus on recovery rather than medication management.
Under your clinician’s supervision, blood levels are monitored and dose adjustments are made to match your individual needs. This approach fosters consistency and lowers the likelihood of relapse.
Benefits of injectable treatments
Opting for long-acting injectable medications offers several advantages over daily oral regimens. You can expect:
Improved medication adherence
- A once-monthly appointment removes the burden of remembering daily pills.
- Reduced risk of diversion or misuse, since the medication is administered by a professional.
- Enhanced focus on therapy and personal growth instead of routine dosing.
Reduced cravings and relapse
Injectable formulations have been linked to lower relapse rates when properly initiated and maintained:
- In a six-month study, 36 percent of participants on Vivitrol plus counseling remained free from opioid use [3].
- Participants who successfully started either Vivitrol or Sublocade experienced similar relapse outcomes, underscoring the value of choosing the right medication for your situation.
By stabilizing your neurochemistry, these treatments help you build resilience against triggers and stressors that might otherwise lead to substance use.
Integrate injections with support
Medication alone is rarely sufficient. For lasting recovery, combine injections with structured support services.
Counseling and behavioral therapy
Engaging in counseling addresses emotional, psychological, and behavioral factors that contribute to substance use. You can work with therapists trained in evidence-based approaches such as cognitive-behavioral therapy (CBT), which:
- Helps you identify and modify thought patterns that lead to drug or alcohol use [4].
- Teaches coping strategies for managing stress, cravings, and social pressures.
- Complements injectable treatment for a holistic approach — see our [sublocade and counseling integration] services.
Peer support networks
Peer support is a cornerstone of relapse prevention. You may benefit from:
- Group therapy sessions that foster accountability and shared insight.
- Young adult sober housing services funded by SAMHSA, providing stable, recovery-oriented living environments.
- 12-step meetings or peer-led recovery groups that reinforce your treatment goals and offer ongoing encouragement.
A strong support network helps you navigate challenges and celebrate milestones in your recovery journey.
Prepare for your treatment program
Your success with injectable MAT depends on careful preparation and medical oversight.
Detox and opioid free period
Before starting Vivitrol, you must complete detoxification and remain opioid-free for the required period:
- 7–10 days for most opioid medications.
- At least 14 days if you have been using methadone.
This waiting period ensures Vivitrol does not trigger sudden withdrawal. For Sublocade, you may begin once withdrawal symptoms have subsided and your provider confirms readiness.
Medical supervision and safety
At Carolina Energetics, you receive:
- Comprehensive medical assessments prior to each injection.
- Vital sign monitoring and laboratory tests to track liver function and overall health.
- Access to naloxone and other emergency interventions in case of overdose or severe reactions.
- Coordination through insurance programs like our [insurance verified injectable mat program] to verify coverage and minimize out-of-pocket costs.
Understand potential side effects
While many people tolerate injectable MAT well, being informed helps you recognize and address adverse events promptly.
Common injection reactions
- Pain, swelling, or redness at the injection site.
- Mild headache, dizziness, or fatigue.
- Nausea or reduced appetite.
These symptoms often resolve within a few days. Notify your provider if they persist or worsen.
Serious risks and precautions
- Risk of accidental opioid overdose due to increased sensitivity following naltrexone treatment.
- Potential liver damage or hepatitis, requiring regular liver function tests.
- Severe injection-site reactions or allergic responses.
- Precipitated withdrawal if Vivitrol is administered before you are opioid-free.
Always inform loved ones about increased overdose risk and ensure naloxone is readily available. Seek emergency care if you experience symptoms of anaphylaxis or severe respiratory depression.
Manage insurance and coverage
Financial concerns should not stand between you and effective treatment. We offer assistance to secure coverage for both Vivitrol and Sublocade.
Vivitrol co-pay savings program
With the Vivitrol Co-pay Savings Program:
- 9 out of 10 eligible patients pay less than $5 per injection.
- 99 percent of Medicaid patients pay $4 or less [5].
- Commercial insurance and self-pay options are available through our [insurance covered vivitrol injection] support.
Sublocade insurance verification support
Our team helps you navigate coverage for Sublocade:
- We submit prior authorizations to Medicaid and commercial plans.
- You can reduce out-of-pocket costs via manufacturer assistance and copay programs.
- Learn more about our [sublocade insurance verification support] and the [sublocade recovery program with insurance].
If unexpected costs arise, we work with you to find alternative funding, including state grants or sliding-scale options.
Strategies for lasting recovery
Maintaining recovery requires ongoing engagement and adaptability. Use these strategies to stay on track.
Monitoring and follow up
- Schedule monthly visits for injections and progress assessments.
- Utilize telehealth for interim check-ins via our [vivitrol treatment with telehealth follow up] or [telehealth sublocade appointment setup].
- Conduct routine urine drug screens or other monitoring methods recommended by NCBI Bookshelf to detect early signs of relapse.
Adjusting treatment plans
Recovery is not one-size-fits-all. Your care team will:
- Review your response to medication and therapy.
- Modify dosing or switch formulations if necessary.
- Introduce emerging interventions such as digital wellness tools or extended peer support.
By staying engaged, you reinforce the skills, habits, and support systems necessary for long-term success. Reach out to schedule your consultation and take the next step toward lasting recovery.
